SARS-CoV-2 infection and immune responses

Area of Science:

• Virology
• Immunology
• Public Health

Background:

• The SARS-CoV-2 pandemic presents an ongoing global health crisis.
• Viral mutations, like Omicron, necessitate continuous vaccine development and pose a threat to current vaccine efficacy.
• No single treatment currently eradicates COVID-19 risk.

Purpose of the Study:

• To review pathogenic mechanisms of SARS-CoV-2 infection and host immune responses.
• To highlight the need for vaccines effective against diverse SARS-CoV-2 variants.
• To discuss the development of therapeutics and public health strategies to end the pandemic.

Main Methods:

• This review synthesizes existing research on SARS-CoV-2 pathogenesis.
• It examines innate and adaptive immune responses to SARS-CoV-2 infection.
• The review analyzes strategies for vaccine development and therapeutic interventions.

Main Results:

• SARS-CoV-2 mutations can lead to immune evasion, reducing vaccine effectiveness.
• Understanding pathogenic mechanisms is key to developing targeted treatments.
• Validated assays are needed to assess the immunogenicity of new vaccines.

Conclusions:

• Effective control of the COVID-19 pandemic requires a multi-pronged approach.
• This includes developing variant-proof vaccines, novel therapeutics, and robust public health measures.
• Continued research into viral evolution and host-pathogen interactions is essential.